{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:43Z","timestamp":1792425643933,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-14-CE15-0001-MECANO"],"award-info":[{"award-number":["ANR-14-CE15-0001-MECANO"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la recherche m\u00e9dicale","doi-asserted-by":"crossref","award":["DQ20170336751"],"award-info":[{"award-number":["DQ20170336751"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00415-020-09807-2","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T04:39:27Z","timestamp":1585370367000},"page":"2083-2089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-3056","authenticated-orcid":false,"given":"Bastien","family":"Joubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-6596","authenticated-orcid":false,"given":"Aude","family":"Belbezier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9109-5604","authenticated-orcid":false,"given":"Julie","family":"Haesebaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-8515","authenticated-orcid":false,"given":"Sylvain","family":"Rheims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Ducray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-267X","authenticated-orcid":false,"given":"G\u00e9raldine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-920X","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-288X","authenticated-orcid":false,"given":"Dimitri","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8798-9058","authenticated-orcid":false,"given":"Giulia","family":"Berzero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9643-1558","authenticated-orcid":false,"given":"Virginie","family":"Desestret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-5952","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,28]]},"reference":[{"key":"9807_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","volume":"55","author":"MC Dalakas","year":"2000","unstructured":"Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55:1531\u20131535","journal-title":"Neurology"},{"key":"9807_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archneur.58.2.225","volume":"58","author":"J Honnorat","year":"2001","unstructured":"Honnorat J, Saiz A, Giometto B et al (2001) Cerebellar ataxia with anti\u2013glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225\u2013230","journal-title":"Arch Neurol"},{"key":"9807_CR3","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain J Neurol 131:2553\u20132563","journal-title":"Brain J Neurol"},{"key":"9807_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.21917","volume":"67","author":"MP Malter","year":"2010","unstructured":"Malter MP, Helmstaedter C, Urbach H et al (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470\u2013478","journal-title":"Ann Neurol"},{"key":"9807_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","volume":"73","author":"E Martinez-Hernandez","year":"2016","unstructured":"Martinez-Hernandez E, Ari\u00f1o H, McKeon A et al (2016) Clinical and immunologic investigations in patients with stiff-person spectrum disorder. JAMA Neurol 73:714\u2013720","journal-title":"JAMA Neurol"},{"key":"9807_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yebeh.2016.10.016","volume":"65","author":"N Hansen","year":"2016","unstructured":"Hansen N, Widman G, Witt J-A et al (2016) Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis. Epilepsy Behav EB 65:18\u201324","journal-title":"Epilepsy Behav EB"},{"key":"9807_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1212\/WNL.55.1.46","volume":"55","author":"J Peltola","year":"2000","unstructured":"Peltola J, Kulmala P, Isoj\u00e4rvi J et al (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46\u201350","journal-title":"Neurology"},{"key":"9807_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","volume":"51","author":"S Liimatainen","year":"2010","unstructured":"Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760\u2013767","journal-title":"Epilepsia"},{"key":"9807_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneuroim.2008.05.015","volume":"199","author":"S Mat\u00e0","year":"2008","unstructured":"Mat\u00e0 S, Muscas GC, Naldi I et al (2008) Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 199:155\u2013159","journal-title":"J Neuroimmunol"},{"key":"9807_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","volume":"30","author":"MP Malter","year":"2015","unstructured":"Malter MP, Frisch C, Zeitler H et al (2015) Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies Seizure. Eur J Epilepsy 30:57\u201363","journal-title":"Eur J Epilepsy"},{"key":"9807_CR11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia 51:1069\u20131077","journal-title":"Epilepsia"},{"key":"9807_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S (2001) Adjusting for multiple testing\u2014when and how? J Clin Epidemiol 54:343\u2013349","journal-title":"J Clin Epidemiol"},{"key":"9807_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","volume":"72","author":"H Ari\u00f1o","year":"2015","unstructured":"Ari\u00f1o H, H\u00f6ftberger R, Gresa-Arribas N et al (2015) Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol 72:874\u2013881","journal-title":"JAMA Neurol"},{"key":"9807_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/dmrr.1189","volume":"27","author":"AM W\u00e4gner","year":"2011","unstructured":"W\u00e4gner AM, Santana A, Her\u0144ndez M et al (2011) Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 diabetes genetics consortium. Diabetes Metab Res Rev 27:493\u2013498","journal-title":"Diabetes Metab Res Rev"},{"key":"9807_CR15","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1212\/NXI.0000000000000416","volume":"5","author":"A Belbezier","year":"2018","unstructured":"Belbezier A, Joubert B, Montero-Martin G et al (2018) Multiplex family with GAD65-Abs neurologic syndromes. Neurol Neuroimmunol Neuroinflammation 5:e416","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"9807_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404","journal-title":"Lancet Neurol"},{"key":"9807_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fneur.2018.01143","volume":"9","author":"M Falip","year":"2018","unstructured":"Falip M, Rodriguez-Bel L, Casta\u00f1er S et al (2018) Hippocampus and insula are targets in epileptic patients with glutamic acid decarboxylase antibodies. Front Neurol 9:1143","journal-title":"Front Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09807-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-020-09807-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09807-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:13:44Z","timestamp":1616890424000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-020-09807-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,28]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["9807"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09807-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,28]]},"assertion":[{"value":"4 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no competing interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the institutional review board of the Hospices Civils de Lyon (CPP SUD-EST II, US registration number 11263). Samples were deposited in the NeuroBioTec biobank (Hospices Civils de Lyon, France, n\u00b0 0033\u201300046, AC-2013\u20131867, NFS96-900).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}